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Background: Evidence is conflicting regarding the effectiveness of creating a low-allergen environment or reducing allergen exposure 
to control asthma exacerbations. 
Objective: This study determined the association of house dust mite (HDM)-specific IgE levels with asthma symptom control, selected 
medications, family history of allergic disease, and exposure to second-hand smoke and household pets. 
Methods: Serum samples from 102 doctor-diagnosed allergic asthma patients and 100 non-atopic controls were subjected to 
enzyme-linked immunosorbent assay using the HDM species Dermatophagoides pteronyssinus (Dp), Dermatophagoides farinae (Df), 
and Blomia tropicalis (Bt) allergens. Point-biserial correlation coefficient, Pearson R correlation, and logistic regression analyses were 
used to determine association of HDM-specific IgE levels with the abovementioned variables. 
Results: Of the 102 cases, 38.24%, 47.06%, and 33.33% were sensitized to Bt, Df, and Dp, respectively. Sensitized patients showed 
greater probability [Bt (OR = 1.21), Df (OR = 1.14), and Dp (OR = 1.35)] to manifest symptoms than those who were not. Obtained 
p-values [Bt (p = 0.73), Df (p = 0.83), and Dp (p = 0.59)], however, proved that HDM-specific IgE levels had no significant contribution in 
predicting or explaining occurrence of asthma symptoms. Bt- and Df-specific IgEs showed moderately weak but significant relationship 
with bambuterol HCl and expectorant, respectively. Patients currently on said medications registered higher HDM-specific IgE levels 
than those who were not. No significant correlation between IgE levels and family history of allergic disease or with exposure to 
second-hand smoke was seen. Dp-specific IgE levels of patients exposed to household pets were significantly lower compared to those 
without exposure. 
Conclusion: This study proves that sensitization to Bt, Df, and Dp allergens is not significantly associated with asthma symptoms and 
control. Although cases were shown to be sensitized to HDMs, their current medications were at least effective in controlling their 
asthma symptoms.
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IntRoduCtIon
Asthma is a chronic inflammation and constriction of the 
respiratory passages caused by interactions among genetic, 
environmental, and social factors [1]. Its clinical manifestations are 
so heterogenous that diagnosis can be subjective and qualitative. 
To  ate, no validated quantitative criteria for asthma diagnosis 
has been established and standardized. Patients are customarily 
evaluated based on airflow obstruction over short periods of 
time, airway or bronchial hyper-responsiveness (AHR or BHR), and 
cellular pathology of the airway [2]. Lung function tests are neither 
easily nor routinely used especially in children [3]. Skin prick tests 
help identify the triggers of the asthma symptoms but cannot be 
regularly done particularly in patients with unstable asthma and 
are at risk of anaphylaxis [4]. Thus, the diagnostic value of blood 
allergen-specific IgEs, being distinct and specific to the allergen 
that triggered their production [5], is often considered in the 
screening, treatment and management of asthma [2]. IgE, which 
is produced upon sensitization to at least one allergen, has been 
proven a strong risk factor for developing asthma [6].
House dust mite (HDM)-specific IgEs are the most consistently 
associated with asthma development [7]. Dermatophagoides 
pteronyssinus (Dp), Dermatophagoides farinae (Df), and Blomia 
tropicalis (Bt) HDMs are among the most implicated asthma 
triggers [8-10]. Thus, this study aimed to determine the association 
of HDM-specific IgE levels with asthma symptom control, selected 
medications, family history of allergic disease, and exposure 
to second-hand smoke and household pets. Past studies have 
investigated the effects of steroids [11-16], β2-agonists [17-18], 
leukotriene receptor antagonists [16-19], and omalizumab [20-21] 
on total and specific IgE. In addition to the above medications, 
expectorant and antibiotic use was also correlated with HDM-
specific IgE levels. 
MAteRIAls And Methods
Asthma and control subjects were university students, 16-21 
years old, without any history of helminth infection, and of Filipino 
descent. A total of 102 doctor-diagnosed allergic asthma patients 
were recruited, and 100 non-atopic individuals without any 
personal or family history of allergy and with specific serum IgE 
levels <50 IU/mL served as controls. History of helminth infection 
was an exclusion criterion to prevent cross-reaction between 
the HDMs and parasites [22]. All case and control subjects, after 
giving their written informed consent, completed standardized 
questionnaires based from the International Study of Asthma 
and Allergy in Childhood and by the International Primary Care 
Airways Group regarding age at onset, duration, and frequency 
of the asthma symptoms, medication(s) received, family history 
of allergic disease, and exposure to cigarette smoke or household 
pets. The design, sampling, experimental protocols, questionnaires 
and other pertinent documents had been presented before and 
approved by the ethics committee of the University of Santo 
Tomas, Manila, Philippines.
Enzyme-linked immunosorbent assay (ELISA) was performed on 
plasma samples of asthma and control subjects following standard 
protocols. All procedures were done at room temperature unless 
otherwise indicated. Briefly, 50 μg/mL of previously prepared HDM 
aqueous extracts [10] diluted with 0.1 M NaHCO3 (pH 8.3) were 
coated onto ELISA plates and incubated overnight at 4°C. Plates 
were blocked with 1% BSA (Sigma, USA) in Phosphate Buffered 
Saline containing 0.05% Tween 20 (PBS-T) for 1 h. Diluted (5×) 
plasma was dispensed onto the wells and incubated overnight 
at 4°C. Biotinylated anti-human IgE (Pharmingen, USA) diluted 
1,000× in blocking buffer (1% BSA in PBS-T) was added and let 
stood for 1h prior to addition of 2,000× dilution of Extravidin-
alkaline phosphatase conjugate (Sigma, USA). Absorbance (405 
nm) was read after 1h colorimetric reaction with p-Nitrophenyl 
phosphate (Sigma, USA). Human IgE (Pharmingen, USA) was used 
as a standard per plate in the calculation of IgE concentration. 
The mean + 1Standard Deviation (SD) of the HDM-specific IgE 
levels (IU/mL) of the control samples served as cut-off values 
in determining positive reactions among the asthma samples. 
All asthma samples that registered values ≥cut-off values were 
considered sensitized by the aforementioned HDM allergens.
For data analysis, SPSS 16 point-biserial correlation coefficient 
was used to determine association of HDM-specific IgE levels 
with selected medications, family history of allergic disease, and 
exposure to second-hand smoke and household pets. Pearson 
R correlation was used to analyze relationship between HDM-
specific IgEs. Logistic regression analysis was done to investigate 
relationship of asthma symptom control (dependent binary 
variable) with independent or explanatory variables such as HDM-
specific IgE levels, use of asthma medications, family history 
of allergic disease, and exposure to second-hand smoke and 
household pets.apallergy.org
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Results
ELISA profile
A total of 202 samples (102 asthma cases and 100 non-atopic 
controls) were analyzed by ELISA for HDM-specific IgE. The 
mean + 1SD of the HDM-specific IgE levels (IU/mL) of the control 
samples served as cut-off values. All asthma samples with IgE 
levels ≥cut-off values (Bt = 25.54 IU/mL, Df = 29.21 IU/mL, and Dp 
= 27.34 IU/mL) were considered sensitized by the aforementioned 
HDM allergens. Highest Bt-, Df- and Dp-specific IgE values 
obtained were 1,328.17 IU/mL, 8,041.62 IU/mL, and 3,509.69 IU/mL, 
respectively. Of the asthma samples, 38.24% was sensitized to Bt, 
47.06% to Df, and 33.33% to Dp. Only 19.61% was sensitized to all 
three HDM species. While 11.76% was sensitized to both Bt and 
Df but not Dp; 8.82% to both Df and Dp but not Bt; none showed 
sensitization to a combination of Bt and Dp. Furthermore, only 
6.86% among the asthma samples became sensitized to Bt alone; 
4.90% to Dp alone; and 6.86% to Df alone. Pearson R correlations 
analysis (Table 1) proved Bt-specific IgE  levels to have moderate 
and significant correlation with Df; Dp to have high and significant 
correlation with Df; and Bt to have no significant correlation with 
Dp. 
HDM-specific IgE correlated with asthma medications and 
symptom control
Asthma symptoms of the 102 cases were categorized into well-
controlled (symptoms manifested ≤2 days per week without 
any interference with normal activity) and totally-controlled (no 
asthma symptoms for the past 12 months). Of the 68 who had 
totally-controlled asthma symptoms, only 24, 29, and 21 were 
sensitized to Bt, Df, and Dp, respectively. Only 15, 19, and 14 of the 
cases with well-controlled asthma symptoms were sensitized to 
Bt, Df, and Dp, respectively (Table 2). 
In a logistic regression analysis of the data, asthma symptom 
control served as dependent binary variable (Y = 1 if asthma 
symptoms were well-controlled and Y = 0 if totally controlled); 
and Bt, Df, and Dp-specific IgE levels, medications used, family 
history of allergic disease, and exposure to second-hand smoke 
and pets were the independent variables. While holding all the 
other independent variables constant, Bt, Df, and Dp-specific IgE 
levels were equal to 1 if subject was sensitized to that particular 
HDM and 0 if otherwise. Table 3 shows that patients sensitized to 
Bt (OR = 1.21), Df (OR = 1.14), and Dp (OR = 1.35) proved greater 
probability to manifest symptoms than those not sensitized. 
However, since Bt (p = 0.73), Df (p = 0.83), and Dp (p = 0.59) 
-specific IgE p-values were >0.05, sensitization to specific HDMs is 
Table 1. Pearson R correlations of IgE among different dust mite spe-
cies (n = 102)
    Bt Df Dp
Bt
Pearson correlation 1 0.561 0.159
Sig. (2-tailed) 8.34E-10 0.111
Df
Pearson correlation 0.561 1 0.811
Sig. (2-tailed) 8.34E-10   5.68E-25
Dp
Pearson correlation 0.159 0.811 1
Sig. (2-tailed) 0.111 5.68E-25
Dp: Dermatophagoides pteronyssinus, Df: Dermatophagoides farinae, Bt: 
Blomia tropicalis. 
Table 2. Participant characteristics
Characteristic Control subjects
n = 100
Asthma cases
n = 102
Totally-controlled
*
n = 68
Well-controlled
†
n = 34
Age (mean) 18.41 18.10 18.24
Gender
male
female
39/100 = 39%
61/100 = 61%
20/68 = 29.41%
48/68 = 70.59%
7/34 = 20.59%
27/34 = 79.41%
Number of cases sensitized to
Bt
Df
Dp
24/68 =  35.29%
29/68 =  42.65%
21/68 =  30.88%
15/34 =  44.12%
19/34 =  55.88%
14/34 =  41.18%
Bt: Blomia tropicalis, Df: Dermatophagoides farinae, Dp: Dermatophagoides pteronyssinus. 
*No asthma symptoms for the past 12 months. 
†Symptoms mani-
fested ≤ 2 days per week without any interference with normal activity. apallergy.org
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said to have no significant contribution in predicting or explaining 
occurrence of asthma symptoms. 
The data was re-run, omitting in the model the independent 
variables like family history of allergic disease and exposure to 
second-hand smoke and pets. Obtained OR values [Bt (OR = 1.22), 
Df (OR = 1.20), and Dp (OR = 1.33)] in Table 4 were very close to 
Table 3. Computed p-values of Bt (p = 0.71), Df (p = 0.76), and Dp 
(p = 0.60) levels were >0.05. Thus, the omitted variables proved no 
significant contribution in the manifestation of asthma symptoms. 
In a point-biserial correlation coefficient analysis of the 
data, HDM-specific IgE levels and asthma medications served 
as continuous and dichotomous variables, respectively. The 
binary variable was equal to 1 if the subject used that particular 
medication and 0 if not. Corrected level of significance was 
0.003125 or 0.3125%. Thus, any p-value <0.3125% level of 
significance indicated significant correlation between the 
two variables. Table 5 shows moderately weak but significant 
relationship between bambuterol HCl use (r = 0.31; p = 0.000) 
and Bt-specific IgE level. Df-specific IgE levels demonstrated weak 
but significant relationship with expectorant (r = 0.25; p = 0.001) 
use. The rest of the medications did not prove any significant 
relationship with the HDM-specific IgE levels.
Association of HDM-specific IgE levels with family history of 
allergic disease, exposure to second-hand smoke and house-
hold pets
Point-biserial correlation coefficient analysis was also used 
here. Binary variable 1 was assigned to cases with family history 
of allergic disease and exposure to second-hand smoke and 
household pets while 0 for those without. Bt (r = −0.07; p = 0.487), 
Df (r = 0.033; p = 0.744), and Dp (r = 0.094; p = 0.351) -specific 
IgE levels were not significantly associated with history of allergic 
disease in the family. Neither was there significant relationship 
between second-hand smoke and serum Bt (r = 0.154; p = 0.124), 
Df (r = 0.157; p = 0.116), or Dp (r = 0.157; p = 0.116) -specific IgE. 
A significant but weak relationship of Dp-specific IgE (r = −0.181; 
p = 0.068) with exposure to household pets was shown. Since 
correlation coefficient was a negative value (Table 6), Dp-specific 
IgE of subjects previously exposed to pets were expected to be 
considerably lower. Bt (r = 0.103; p = 0.302) and Df (r = −0.111; p 
= 0.265) -specific IgE levels were not significantly associated with 
household pet exposure. Dog, cat, hamster, rat, rabbit, guinea 
pig, bird, fish, and turtle were among the pets the subjects were 
exposed to. 
dIsCussIon
ELISA demonstrated multiple HDM-specific IgE reactivity of the 
subjects in this study. Although IgEs are said to be distinct and 
specific to the allergen that triggered their production [10], Dp- 
and Df-specific IgEs have been found to be highly cross-reactive 
[9]. This study, however, does not recognize whether the multiple-
reactivity seen in some of the subjects is due to cross-reactions or 
actual presence of HDM-specific IgEs in their sera.
At present, there is conflicting evidence about whether 
measures to create a low-allergen environment in patient’s home 
Table 3. Relationship of house dust mite-specific IgE with asthma 
control (Asthma control as dependent variable; Bt, Df, Dp IgE lev-
els, medications, family history of allergic disease, and exposure to 
second-hand smoke and pets as independent variables)
Asthma control OR SE z p-value 95% CI
Bt IgE 1.21 0.68 0.35 0.73 0.41-3.62
Df IgE 1.14 0.71 0.21 0.83 0.34-3.86
Dp IgE 1.35 0.75 0.54 0.59 0.45-4.02
Bt: Blomia tropicalis, Df: Dermatophagoides farinae, Dp: Dermatophagoides 
pteronyssinus. Odds ratios (OR) were computed using logistic regression. 
Dependent variable was whether the asthma symptoms were well-con-
trolled (symptoms manifested ≤2 days per week without any interference 
with normal activity; Y = 1) or totally-controlled (no asthma symptoms 
for the past 12 months; Y = 0). The independent variables were Bt, Df, Dp 
IgE levels, medications, family history of allergic disease, and exposure to 
second-hand smoke and pets. Bt, Df and Dp IgE levels as binary variables 
were equal to 1 if patient was sensitized and 0 if otherwise. n = 102.
Table 4. Relationship of house dust mite-specific IgE with asthma 
control (Asthma control as dependent variable; Bt, Df, Dp IgE levels 
and medications as independent variables)
Asthma control OR SE z p-value 95% CI
Bt IgE 1.22 0.66 0.38 0.71 0.43-3.51
Df IgE 1.20 0.73 0.31 0.76 0.37-3.97
Dp IgE 1.33 0.71 0.52 0.60 0.46-3.80
Bt: Blomia tropicalis, Df: Dermatophagoides farinae, Dp: Dermatophagoides 
pteronyssinus. Odds ratios (OR) were computed using logistic regression. De-
pendent variable was whether the asthma symptoms were well-controlled 
(symptoms manifested ≤2 days per week without any interference with 
normal activity; Y = 1) or totally-controlled (no asthma symptoms for the 
past 12 months; Y = 0). The independent variables were Bt, Df, Dp IgE levels 
and medications. Bt, Df and Dp IgE levels as binary variables were equal to 
1 if patient was sensitized and 0 if otherwise. n = 102.apallergy.org
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or reduced exposure to indoor allergens are effective at reducing 
asthma symptoms. While aeroallergens are often implicated in 
asthma development, this study showed that HDM-specific IgE   
levels were not associated with prevalence of asthma symptoms. 
It was also mentioned previously that HDM did not significantly 
influence asthma severity [23]. Furthermore, HDM-sensitized 
children with moderate to severe asthma did not demonstrate 
differences in respiratory symptoms or lung function after a 
year of using mite-occlusive mattress cover [24]. Meanwhile, the 
National Asthma Education and Prevention Program recommends 
identifying allergens to which an individual is sensitized and 
employing strategies of allergen avoidance or reduced exposure 
[25]. Considering that asthma results from the complex interplay 
between genetic susceptibility and ubiquitous environmental 
factors, avoiding the latter completely may not only seem 
impossible but impractical and very limiting to the patient. It is 
more important, therefore, to resolve the HDM level that could 
result to either sensitization or tolerance since sensitization to 
HDMs among asthmatic adolescents has been demonstrated to 
be not significantly different from non-asthmatics [26]. 
Table 5. Correlation coefficient and p-values between house dust mite-specific IgE and medications (n = 102)
Medications used
Bt Df Dp
CC p-value CC p-value CC p-value
Salbutamol/ Albuterol 0.04 0.041   0.10 0.019 0.06 0.04
Salmeterol 0.05 0.039 −0.05 0.039 −0.03 0.05
Terbutaline sulfate −0.05 0.039 −0.05 0.041 −0.01 0.06
Procaterol HCl −0.03 0.049 −0.02 0.051 −0.02 0.05
Bambuterol HCl 0.31 0.000   0.00 0.062 −0.02 0.05
Budesonide + formoterol 0.15 0.008 −0.02 0.052 −0.02 0.05
Corticosteroids 0.22 0.002   0.12 0.014 0.08 0.03
Albuterol + ipratropium −0.03 0.049 −0.02 0.051 −0.02 0.05
Antihistamine −0.05 0.039 −0.04 0.045 −0.01 0.06
Aminophylline −0.02 0.051 −0.02 0.051 −0.02 0.05
Montelukast −0.04 0.045 −0.03 0.048   0.00 0.06
Mucolytic −0.05 0.038 −0.05 0.039 −0.05 0.04
Nasal decongestant −0.03 0.049 −0.02 0.053 −0.02 0.05
Expectorant 0.14 0.009   0.25 0.001 0.02 0.05
Antibiotics −0.06 0.035 −0.05 0.037 −0.05 0.04
Allergy sensitization −0.03 0.049 −0.02 0.051 −0.02 0.05
Bt: Blomia tropicalis, Df: Dermatophagoides farinae, Dp: Dermatophagoides pteronyssinus, CC: correlation coefficient. Corrected level of significance = 0.003125 
or 0.3125%. General rule in interpreting the correlation coefficient: 0-0.25, weak relationship; 0.26-0.5, moderately weak relationship; 0.51-0.75, moderately 
strong relationship; 0.76-1, strong relationship.
Table 6. Correlation coefficient and p-values between house dust mite-specific IgE and family history of allergic disease, exposure to SHS, and 
household pets (n = 102)
Factor
Bt Df Dp
CC p-value CC p-value CC p-value
Family history of allergic disease −0.070 0.487    0.033 0.744    0.094 0.351
Exposure to SHS    0.154 0.124    0.157 0.116    0.157 0.116
Exposure to household pets     0.103 0.302 −0.111 0.265 −0.181 0.068
SHS: second hand smoke, Bt: Blomia tropicalis, Df: Dermatophagoides farinae,  Dp: Dermatophagoides pteronyssinus, CC: correlation coefficient. General 
rule in interpreting the correlation coefficient: 0-0.25, weak relationship; 0.26-0.5, moderately weak relationship; 0.51-0.75, moderately strong 
relationship; 0.76-1, strong relationship.apallergy.org
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Although previous studies have demonstrated that resistance 
or susceptibility to a certain drug is genetically-linked [27, 28], 
the interactions between and among HDM-specific IgE levels, 
asthma medications, and genetic make-up are not altogether 
known. Bt and Df-specific IgE levels showed moderately weak 
but significant associations with bambuterol HCl and expectorant 
use, respectively. Subjects currently on said medications during 
blood sample collection registered higher HDM-specific IgE levels 
compared to those who were not. This finding, however, is not 
conclusive and may only be due to chance. Increased inflammation 
and mucus production could have required increased amount 
of medication. Thus, a more controlled study using a bigger 
population size must be done to substantiate this. Factors that 
influence effectiveness of asthma medications, such as route of 
administration, dose, and period of treatment, in association with 
HDM-specific IgE production and genetic factors must also be 
considered. 
Family history of allergic disease, which is considered strong 
risk factor in allergic rhinitis or asthma development [29], and 
second-hand smoke were not associated with HDM-specific 
IgE levels. While cigarette smoking is currently considered an 
important predictor of asthma severity and poor asthma control 
[30], our results agree with that previously done on a selected 
Japanese population in which second-hand smoke showed 
no association with HDM sensitization [31]. Moreover, subjects 
previously exposed to household pets registered lower Df-specific 
IgE levels. Reduced asthma incidence in schoolchildren exposed 
to pets during their first year of life may be attributed to the IgG 
and IgG4 produced against the pets, without risk of sensitization 
and asthma development [32, 33]. Yet, this seems to confer only a 
protective but not a preventive effect [29].
In conclusion, this study proves that sensitization to Bt, Df, and 
Dp allergens is not significantly associated with asthma symptoms 
and control. Although cases were shown to be sensitized to HDMs, 
their current medications were at least effective in controlling their 
asthma symptoms. It is further recommended that future studies 
also focus on genetic factors associated with HDM sensitization 
and response to therapy. 
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